KLF15 regulates endobiotic and xenobiotic metabolism
- PMID: 32694878
- DOI: 10.1038/s42255-019-0054-7
KLF15 regulates endobiotic and xenobiotic metabolism
Abstract
Hepatic metabolism and elimination of endobiotics (for example, steroids, bile acids) and xenobiotics (for example, drugs, toxins) is essential for health. While the enzymatic (termed phase I-II) and transport machinery (termed phase III) controlling endobiotic and xenobiotic metabolism (EXM) is known, understanding of molecular nodal points that coordinate EXM function in physiology and disease remains incomplete. Here we show that the transcription factor Kruppel-like factor 15 (KLF15) regulates all three phases of the EXM system by direct and indirect pathways. Unbiased transcriptomic analyses coupled with validation studies in cells, human tissues, and animals, support direct transcriptional control of the EXM machinery by KLF15. Liver-specific deficiency of KLF15 (Li-KO) results in altered expression of numerous phase I-III targets, and renders animals resistant to the pathologic effects of bile acid and acetaminophen toxicity. Furthermore, Li-KO mice demonstrate enhanced degradation and elimination of endogenous steroid hormones, such as testosterone and glucocorticoid, resulting in reduced male fertility and blood glucose levels, respectively. Viral reconstitution of hepatic KLF15 expression in Li-KO mice reverses these phenotypes. Our observations identify a previously unappreciated transcriptional pathway regulating metabolism and elimination of endobiotics and xenobiotics.
References
-
- Kuntz, E., Gundermann, K. J. & Schneider, E. “Essential” phospholipids in hepatology (experimental and clinical tests) (in Russian). Ter. Arkh 66, 66–72 (1994). - PubMed
-
- Urquhart, B. L., Tirona, R. G. & Kim, R. B. Nuclear receptors and the regulation of drug-metabolizing enzymes and drug transporters: implications for interindividual variability in response to drugs. J. Clin. Pharmacol. 47, 566–578 (2007). - DOI
-
- Chai, X., Zeng, S. & Xie, W. Nuclear receptors PXR and CAR: implications for drug metabolism regulation, pharmacogenomics and beyond. Expert Opin. Drug Metab. Toxicol. 9, 253–266 (2013). - DOI
-
- Copple, I. M., Goldring, C. E., Kitteringham, N. R. & Park, B. K. The Nrf2-Keap1 defence pathway: role in protection against drug-induced toxicity. Toxicology 246, 24–33 (2008). - DOI
-
- Baird, L. & Dinkova-Kostova, A. T. The cytoprotective role of the Keap1-Nrf2 pathway. Arch. Toxicol. 85, 241–272 (2011). - DOI
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Molecular Biology Databases
Research Materials